SectorPharmaceutical
Established Date24/02/2017
Listing Date25/03/2022
ExchangeNASDAQ Stock Exchange
Full-time Employees21
Fiscal Year Ends31/12
Security TypeCommon stock
Office address1300 El Camino Real, Suite 100, Menlo Park, California 94025
Business
IntroductionAN2 Therapeutics, Inc., was incorporated in Delaware on February 24, 2017 and commenced operations in November 2019. The Company is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapies using its boron chemistry platform. Its R&D pipeline targets the fields of blood diseases, infectious diseases and oncology.
